Strumento inattivo

Altre lingue Daiichi Sankyo Company, Limited Other OTC

Azioni

DSNKY

US23381D1028

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Japan's Nikkei closes at 3-week high on US rate-cut outlook, tech boost	07/05
Japan's Nikkei climbs on Fed rate-cut outlook, tech boost	07/05
Remsons, Daiichi Infotainments Form Joint Venture	30/04
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	29/04
AstraZeneca PLC and Daiichi Sankyo Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Improved PFS in HER2-Low and Ultralow	29/04
AstraZeneca makes progress with Truqap and Enhertu cancer treatments	29/04
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study	29/04
Hipgnosis Songs Fund backs new Blackstone bid	29/04
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial	29/04
Scholz sichert Pharmabranche weiter Unterstützung zu	25/04
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	25/04
Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	25/04
AstraZeneca upbeat as cancer drugs underpin sales growth	25/04
Le marché devient un peu timbré	25/04
Daiichi Sankyo : Announces Determination of Matters Relating to Acquisition and Cancellation of Own Shares(213.5KB	25/04
Daiichi Sankyo : FY2023 Reference Dat	25/04
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	25/04
Daiichi Sankyo Company, Limited Announces Dividend for the Year Ended March 31, 2024, Payable on June 18, 2024 and Provides Dividend Guidance for Second Quarter of Fiscal Ending March 31, 2025	25/04
Daiichi Sankyo Company, Limited Provides Dividend Guidance for Full Fiscal Ending March 31, 2025	25/04
Daiichi Sankyo Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	25/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Daiichi Sankyo Company, Limited Other OTC

Azioni

DSNKY

US23381D1028

Altre lingue

Filtri